FIRST AND FURTHER LIVER DECOMPENSATION IN PATIENTS WITH METABOLIC-DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE: WHAT CLINICAL IMPACT?

被引：0

作者：

Pennisi, G. ^{[3
]}

Vigano, M. ^{[1
]}

Fracanzani, A. L. ^{[2
]}

Miele, L. ^{[4
]}

Bugianesi, E. ^{[5
]}

D'Ambrosio, R. ^{[6
]}

Ravaioli, F. ^{[7
]}

Schepis, F. ^{[7
]}

Marra, F. ^{[8
]}

Aghemo, A. M. G. ^{[9
]}

Svegliati, Baroni G. ^{[10
]}

Masarone, M. ^{[11
]}

Valenti, L. ^{[12
]}

Armandi, A. ^{[5
]}

Ciccioli, C. ^{[3
]}

Cerini, F.

Colecchia, A. ^{[13
]}

Gasbarrini, A. ^{[4
]}

Infantino, G. ^{[3
]}

Liguori, A. ^{[4
]}

Pelusi, S. ^{[12
]}

Saltini, D. ^{[7
]}

Lampertico, P. ^{[6
]}

Persico, M. ^{[4
,14
]}

Pugliese, N. ^{[9
]}

Tulone, A. ^{[3
]}

Di Marco, V. ^{[3
]}

Camma, C. ^{[3
]}

Petta, S. ^{[3
]}

机构：

[1] Univ Milan, Osped San Giuseppe, Hepatol Unit, Milan, Italy

[2] Univ Milan, Policlin Hosp, Ca Granda IRCCS Fdn, Dept Pathophysiol & Transplantat, Milan, Italy

[3] Univ Palermo, Sect Gastroenterol & Hepatol, Dipartimento Promoz Salute, Med Interna & Specialist Eccellenza PROMISE, Palermo, Italy

[4] A Gemelli Univ Policlin Fdn IRCCS, Dept Med & Surg Sci, I-00168 Rome, Italy

[5] Univ Torino, Div Gastroenterol, Dept Med Sci, Turin, Italy

[6] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Gastroenterol & Hepatol, Milan, Italy

[7] Azienda Osped Univ Modena & Univ Modena & Reggio, Div Gastroenterol, Modena, Italy

[8] Univ Florence, Dipartimento Med Sperimentale & Clin, Res Ctr DENOTHE, Florence, Italy

[9] IRCCS Humanitas Res Hosp, Div Internal Med & Hepatol, Dept Gastroenterol, I-20089 Rozzano, Italy

[10] Univ Politecn Marche, Liver Injury & Transplant Unit, I-60121 Ancona, Italy

[11] Univ Salerno, Scuola Med Salernitana, Dept Med Surg & Dent, Internal Med & Hepatol Unit, Salerno, Italy

[12] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Transfus Med, Translat Med, IRCCS, Milan, Italy

[13] Univ Modena & Reggio Emilia, Univ Hosp Modena & Reggio Emilia, Dept Specialist Med, Gastroenterol Unit, Largo Pozzo 71, I-41125 Modena, Italy

[14] Univ Naples Federico II, Dept Gen Surg Endocrinol Orthopaed & Rehabil, Sch Med, Naples, Italy

来源：

DIGESTIVE AND LIVER DISEASE | 2024年 / 56卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

OC.05.2

引用

页码：S149 / S149

页数：1

共 50 条

[21] Metabolic Dysfunction-Associated Steatotic Liver Disease
Ali, Sajjadh M. J.
Lai, Michelle
ANNALS OF INTERNAL MEDICINE, 2025, 178 (01) : ITC1 - ITC17
[22] GUT MYCOBIOME IN THE SPECTRUM OF METABOLIC-DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): FROM MASH TO HEPATOCELLULAR CARCINOMA
Alvares-da-Silva, Mario
Perlin, Cassio
Keingeski, Melina
Basso, Bruno
Medeiros, Juliane
Borges, Francis
Uribe-Cruz, Carolina
HEPATOLOGY, 2024, 80 : S669 - S670
[23] SCREENING FOR METABOLIC-DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE AND ADVANCED FIBROSIS AMONG PATIENTS WITH OBESITY: A COST-EFFECTIVENESS ANALYSIS
Mohanty, Arpan
Wang, Yin
Stoecker, Charles
GASTROENTEROLOGY, 2024, 166 (05) : S1667 - S1667
[24] IMPACT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE ON THE INCIDENCE OF OSTEOPOROSIS
Khan, Wajiha
Kim, David
Shari, Ariana
Khan, Hamza
Le, Alexander
Hawryluk, Christopher
Bobkov, Ivan
Al-Khazraji, Ahmed
Hajifathalian, Kaveh
HEPATOLOGY, 2024, 80 : S819 - S820
[25] Recruitment of Minority Patients in Metabolic Dysfunction-Associated Steatotic Liver Disease Clinical Trials
Park, Sarah
Wollstein, Yael
Hutchison, Alan L.
Paul, Sonali
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1393 - S1393
[26] Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease
Michalczuk, Matheus Truccolo
Longo, Larisse
Keingeski, Melina Belen
Basso, Bruno de Souza
Guerreiro, Gabriel Tayguara Silveira
Ferrari, Jessica T.
Vargas, Jose Eduardo
Oliveira, Claudia P.
Uribe-Cruz, Carolina
Cerski, Carlos Thadeu Schmidt
Filippi-Chiela, Eduardo
Alvares-da-Silva, Mario Reis
WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (01) : 75 - 90
[27] The Outcomes of Liver Transplantation in Severe Metabolic Dysfunction-Associated Steatotic Liver Disease Patients
Paklar, Natasa
Mijic, Maja
Filipec-Kanizaj, Tajana
BIOMEDICINES, 2023, 11 (11)
[28] Apolipoprotein C-III in association with metabolic-dysfunction associated steatotic liver disease: A large, multicenter study
Kouvari, Matina
Valenzuela-Vallejo, Laura
Guatibonza-Garcia, Valentina
Verrastro, Ornella
Axarloglou, Evangelos
Mylonakis, Sophia C.
George, Jacob
Papatheodoridis, Georgios
Mingrone, Geltrude
Mantzoros, Christos S.
CLINICAL NUTRITION, 2024, 43 (12) : 101 - 108
[29] A PROSPECTIVE ASSESSMENT OF THE IMPACT OF DECOMPENSATION OF CIRRHOSIS ON PATIENT-REPORTED OUTCOMES IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
O'Connor, Ian
Mospan, Andrea
Schoen, Cheryl
Barritt, Alfred
Sanyal, Arun
HEPATOLOGY, 2024, 80 : S843 - S844
[30] Histological and clinical disease progression in patients with metabolic dysfunction-associated steatotic liver disease using paired liver biopsy
Ekelik, Merve
Gokce, Dilara Turan
Gumussoy, Mesut
Kiremitci, Saba
Bodakci, Emin
Yilmaz, Volkan
Karayel, Sevinc Tugce
Duman, Serkan
Ellik, Zeynep Melekoglu
Ozercan, Abdullah Mubin
Er, Ramazan Erdem
Karakaya, Fatih
Gokcan, Hale
Elhan, Atilla
Savas, Berna
Toruner, Murat
Idilman, Ramazan
JOURNAL OF HEPATOLOGY, 2024, 80 : S479 - S479

← 1 2 3 4 5 →